smerv
-
RT @: RT @: Personal note: Without good biomarkers, we can not do more efficient studies w/fewer pts
11:47 AM Dec 13th
from web
-
RT @: RT @: Herceptin Combinations Improve Survival, Lessen Heart Toxicity
11:45 AM Dec 13th
from web
-
Recap Of Three Adjuvant Hormonal Therapy Studies -
2:31 PM Dec 11th
from ShareThis.com
-
What Would Jesus Buy? WSJ.com - Shopping and Gomorrah
7:28 AM Dec 11th
from web
-
RT @: ASH Update: CLL Treatment with Dr. Bill Wierda from M.D. Anderson
12:49 PM Dec 9th
from web
-
RT @: CTRC-AACR 2009 San Antonio Breast Cancer Symposium begins today our doctors will be blogging the event starting tomo
...
12:49 PM Dec 9th
from web
-
RT @: 253 of MD Anderson Faculty Rank in “Best Doctors in America”...Best Doctors was founded by two Harvard Medical School Phys
...
7:32 AM Dec 9th
from web
-
Pistachios May Reduce Lung Cancer Risk:
7:27 AM Dec 9th
from web
-
RT @: Higher risk of 2nd primary cancers in patients who are initially diagnosed with a tobacco or alcohol-related cancer
...
2:17 PM Dec 8th
from web
-
RT @: The Cyber Sea: World's First Internet Undersea Science Station Boots Up [Slide Show]
2:04 PM Dec 8th
from web
-
RT @: Antioxidant Compound Reduced Colorectal Metachronous Adenomas Incidence: via AACR Frontiers in C
...
2:02 PM Dec 8th
from web
-
Carfilzomib induces response in multiple myeloma patients, reduces neuropathy.
2:01 PM Dec 8th
from web
-
Dennis Slamon, M.D., Ph.D., to Present Updated Results of Herceptin Trial:
12:28 PM Dec 8th
from web
-
Coffee Consumption Associated with Reduced Risk of Advanced Prostate Cancer: via @
11:14 AM Dec 8th
from web
-
Decline in Breast Cancer: Not Just Because of Hormone Therapy: via @
11:13 AM Dec 8th
from web
-
RT @: Frontiers in Cancer Prevention Research Conf. Highlights New Science in Diet & Lifestyle. Teleconference audio up. http:
...
1:27 PM Dec 7th
from web
-
miRNA pathway variations show risk of recurrence, second cancer for head/neck cancer patients
1:24 PM Dec 7th
from web
-
JAK2 inhibitor helps myelofibrosis patients in phase II trial.
11:30 AM Dec 7th
from web
-
New drug acts against drug-resistant chronic myeloid leukemia.
11:25 AM Dec 7th
from web
-
RT @: So rare in MSM. RT @ use links, whether or not they're at your station. "send them away to get them bac
...
11:24 AM Dec 7th
from web
|
- Name Scott Merville
- Location Houston, Texas
- Bio Communications program manager basic and translational research, University of Texas M. D. Anderson Cancer Center, camper, hiker, reader.
|